Clinicopathologic Conference, Glioblastonoma, WHO grade IV of IV, with Methylation of the MGMT Promoter
NEJM 366:2112-2120, Case 17-2012, 2012
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011
Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Primary Brain Tumors:Review of Etiology Diagnosis and Treatment
Am Fam Physician 49:787-797, Newton,H.B., 1994
Neuropathologic Correlated of Persistent Neurologic Deficit in Lithium Intoxication
Ann Neurol 36:928-931, Schneider,J.A.&Mirra,S.S., 1994
Brain Tumors in Children
J Pediatr 114:511-519, Kadota,R.P.,et al, 1989